Nanalysis Scientific (CVE:NSCI) Stock Price Down 1.4% – What’s Next?
by Kim Johansen · The Markets DailyNanalysis Scientific Corp. (CVE:NSCI – Get Free Report)’s share price was down 1.4% during trading on Thursday . The stock traded as low as C$0.35 and last traded at C$0.36. Approximately 76,850 shares changed hands during trading, an increase of 56% from the average daily volume of 49,351 shares. The stock had previously closed at C$0.36.
Nanalysis Scientific Price Performance
The stock has a market capitalization of C$40.70 million, a P/E ratio of -3.00 and a beta of 0.72. The stock’s fifty day moving average is C$0.39 and its 200-day moving average is C$0.41. The company has a debt-to-equity ratio of 71.72, a current ratio of 1.42 and a quick ratio of 1.11.
Nanalysis Scientific Company Profile
Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.
Recommended Stories
- Five stocks we like better than Nanalysis Scientific
- ETF Screener: Uses and Step-by-Step Guide
- Battle of the Retailers: Who Comes Out on Top?
- 3 Best Fintech Stocks for a Portfolio Boost
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- When to Sell a Stock for Profit or Loss
- MarketBeat Week in Review – 10/28 – 11/1